Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 807 results for "sandoz inc"

Sandoz Canada Inc. launches PrTOBRAMYCIN INHALATION SOLUTION, ...

(GLOBE NEWSWIRE) -- Sandoz Canada Inc. announced the launch of PrTOBRAMYCIN INHALATION SOLUTION, an authorized generic version of PrTOBI*, currently marketed by Novartis Pharmaceuticals Canada Inc. PrTOBRAMYCIN INHALATION SOLUTION, a respiratory ... Benzinga.com, 1 month ago
[x]  
India Infoline

Sandoz and Macleods recall drugs from US markets

Sandoz Inc is recalling over 2,70,000 bottles of hypertension tablets manufactured by Hyderabad-based Mylan Laboratories, according to the USFDA. In addition, Tablets used to treat Parkinson's disease manufactured by Macleods Pharmaceuticals are also being ...
 India Infoline2 months ago Sandoz Inc, Macleods Pharma recall 2 drugs made in India  Money Control2 months ago
[x]  

Lannett (LCI) Arthur P. Bedrosian on Q3 2016 Results - Earnings Call Transcript

Lannett Co., Inc. (NYSE: LCI ) Q3 2016 Earnings Call May 03, 2016 4:30 pm ET Executives Robert Jaffe - President & Chief Executive Officer, Robert Jaffe Co. LLC Arthur P. Bedrosian - Chief Executive Officer & Director Martin P.
 Seeking Alpha1 day ago Momenta Pharmaceuticals' (MNTA) CEO Craig Wheeler on Q1 2016 Results - Earnings Call Transcript  Seeking Alpha1 day ago Momenta Pharmaceuticals Reports First Quarter 2016 Financial Results  4 Traders2 days ago Anacor Pharmaceuticals to Report First Quarter 2016 Financial Results on May 10, 2016  Pharmaceutical Tech.com3 hours ago
[x]  

Aequus Pharmaceuticals Inc. (AQSZF: OTCQB) | Aequus Pharmaceuticals Initiates Promotional Efforts for VISTITAN(TM) in Canada

) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company") announced today that it has initiated commercial activities for PR Vistitan (bimatoprost 0.03%, ophthalmic solution) in the Canadian market, which is a ...
 OTC Markets1 week ago Aequus Pharmaceuticals Initiates Promotional Efforts for VISTITAN(TM) in Canada  Sys-Con Italia1 week ago
[x]  

Market Research Rerports Inc: Global Immunotherapy Drugs Market to grow at a CAGR of 11.52% during the period 2016 - 2020

Recent Market Articles 04/12/2016 10:00 AM ET 04/12/2016 10:00 AM ET 04/12/2016 4:00 AM ET Market Research Reports, Inc. has announced the addition of "Global Immunotherapy Drugs 2016 - 2020" research report to their website ...
 Bloomberg3 weeks ago

Novartis Binocrit's Subcutaneous Formula Gets EC Approval

Novartis NVS announced that its generic arm, Sandoz, has received approval from the European Commission (EC) for a type II variation for the addition of a subcutaneous administration of Binocrit (epoetin alfa) in its nephrology indication. We ...
 Yahoo! Finance UK and Ireland3 weeks ago
Bidness Etc

What Amgen's sBLA for Expanded Enbrel Use Means for the Company

Amgen Inc. ( NASDAQ:AMGN ) announced earlier this week that its supplemental Biologics License Application (sBLA) for its best-selling rheumatoid arthritis drug, Enbrel, has been accepted by the Food and Drug Administration (FDA) for another ...
 Bidness Etc1 month ago BioQ Pharma Expands U.S. License and Supply Agreement to Commercialize Third Ready-to-Use Infusion Product  4 Traders1 week ago
[x]  

BL Twenty Years Ago Today: Ciba, Sandoz announce merger to form Novartis

Ciba-Geigy AG and Sandoz AG, Switzerland's two largest Pharmaceuticals companies, said they will merge to form the world's second-largest drug company with estimated sales of 26 billion Swiss francs ($21.8 billions). The companies said in a joint ...
 Hindu Business Line1 month ago
TeleTrader.com

CORRECTING and REPLACING Apricus Biosciences to Host Live Webcast KOL Event on May 9th Addressing Vitaros and Erectile Dysfunction Population

In a release issued under the same headline earlier today by Apricus Biosciences, Inc. (Nasdaq:APRI), please note that in the second line of the subheadof the release, "2H 2016"should instead be "Q32016." The corrected release follows: Presentation ...
 Pharmacy Choice1 day ago CORRECTING and REPLACING -- Apricus Biosciences to Host Live Webcast KOL Event on May 9th Addressing Vitaros® and Erectile Dysfunction Population  Financial Buzz1 day ago CORRECTING and REPLACING — Apricus Biosciences to Host Live Webcast KOL Event on May 9th Addressing Vitaros® and Erectile Dysfunction Population  PM 3601 day ago Apricus Biosciences to Announce Corporate Update and First Quarter 2016 Financial Results  Financial Buzz1 day ago
[x]  
Nasdaq

Anacor Pharmaceuticals' Revenue Doubles But Misses Views

By Maria Armental Anacor Pharmaceuticals Inc. on Monday reported revenue more than doubled in the December quarter bolstered by its toenail fungus treatment. Still, results missed Wall Street views, sending shares down 6% to $60 in after-hours ...
 4 Traders2 months ago Novartis Names New Ethics Officer  Morningstar.com2 days ago Shannon Klinger to Replace Eric Cornut as Novartis's Ethics Officer  ADVFN India2 days ago Novartis Feels the Effect Of Drop in Gleevec ...  ADVFN UK1 week ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less